Novo Nordisk says Wegovy has about 200,000 weekly prescriptions in the U.S., where it brought in nearly $1.9 billion in first-quarter sales
Some possible long-term risks may include: Reduced sensitivity to growth hormone over time Small changes in insulin or blood sugar levels Higher IGF-1 levels, which may affect cell growth These effects are uncommon but worth watching
Given that CoQH2 serves as an alternative anti-ferroptosis system operating in parallel with GPX4, the differential metabolic environments between malignant and normal cells likely contribute to the divergent effects of lactate on ferroptosis sensitivity observed across these cellular contexts
L., Mate, A., Monserrat, M
Expert Clinical Summary From a medical and clinical trial perspective, fluid loss is an indirect, secondary response to how GLP-1 medications alter digestion
Cagrilintide and Retatrutide for Men: Uses, Evidence, and UK Access Cagrilintide and retatrutide for men represent two of the most closely watched investigational medicines in obesity and metabolic medicine
